HEADER TRANSFERASE/HYDROLASE 24-AUG-09 3IRX TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2- TITLE 3 OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL)-5-(5-METHYL-1,3,4-OXADIAZOL-2- TITLE 4 YL)PENT-1-ENYL)-2-METHOXY-3-METHYLBENZOTHIOATE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: P66 RT; COMPND 5 EC: 2.7.7.49, 2.7.7.7, 3.1.26.4; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: P51 RT; COMPND 12 EC: 2.7.7.49, 2.7.7.7; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11678; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) RIL; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 11 ORGANISM_COMMON: HIV-1; SOURCE 12 ORGANISM_TAXID: 11678; SOURCE 13 GENE: GAG-POL; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS NNRTI, NONNUCLEOSIDE INHIBITOR, AIDS, HIV, P51/P66, ADAM, ASPARTYL KEYWDS 2 PROTEASE, CELL MEMBRANE, CYTOPLASM, DNA INTEGRATION, DNA KEYWDS 3 RECOMBINATION, DNA-DIRECTED DNA POLYMERASE, ENDONUCLEASE, HYDROLASE, KEYWDS 4 LIPOPROTEIN, MEMBRANE, METAL-BINDING, MULTIFUNCTIONAL ENZYME, KEYWDS 5 MYRISTATE, NUCLEASE, NUCLEOTIDYLTRANSFERASE, NUCLEUS, KEYWDS 6 PHOSPHOPROTEIN, PROTEASE, RNA-BINDING, RNA-DIRECTED DNA POLYMERASE, KEYWDS 7 TRANSFERASE, VIRAL NUCLEOPROTEIN, VIRION, ZINC, ZINC-FINGER, KEYWDS 8 TRANSFERASE-HYDROLASE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.HO,E.ARNOLD REVDAT 3 06-SEP-23 3IRX 1 REMARK REVDAT 2 13-OCT-21 3IRX 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 HETSYN REVDAT 1 07-APR-10 3IRX 0 JRNL AUTH M.D.CULLEN,W.C.HO,J.D.BAUMAN,K.DAS,E.ARNOLD,T.L.HARTMAN, JRNL AUTH 2 K.M.WATSON,R.W.BUCKHEIT,C.PANNECOUQUE,E.DE CLERCQ,M.CUSHMAN JRNL TITL CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN JRNL TITL 2 COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE JRNL TITL 3 RT INHIBITOR (E)-S-METHYL JRNL TITL 4 5-(1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDROBENZO[D]OXAZOL-5-YL) JRNL TITL 5 -5-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PENT-1-ENYL) JRNL TITL 6 -2-METHOXY-3-METHYLBENZOTHIOATE. JRNL REF J.MED.CHEM. V. 52 6467 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19775161 JRNL DOI 10.1021/JM901167T REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.1 REMARK 3 NUMBER OF REFLECTIONS : 28872 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.289 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1414 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 90.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3IRX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000054789. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97770 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28872 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.2 REMARK 200 DATA REDUNDANCY : 12.60 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 92.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2ZD1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM IMMIDAZOLE PH 6.4, 10% PEG 8000, REMARK 280 100 MM AMMONIUM SULFATE, 10 MM SPERMINE AND 30 MM MAGNESIUM REMARK 280 SULFATE. , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 82.31950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.69250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 82.31950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.69250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 48720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 MET A -1 REMARK 465 GLY A 555 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 6 135.97 -31.62 REMARK 500 LYS A 20 53.68 -142.89 REMARK 500 ASN A 54 106.97 -50.19 REMARK 500 LYS A 70 173.13 69.92 REMARK 500 LYS A 82 4.17 -69.48 REMARK 500 GLN A 85 -178.16 -64.85 REMARK 500 GLN A 91 45.21 -99.22 REMARK 500 ASP A 123 21.67 -72.97 REMARK 500 ASN A 136 12.73 56.93 REMARK 500 ASN A 175 58.63 -150.61 REMARK 500 TYR A 183 87.96 -159.56 REMARK 500 MET A 184 -134.49 70.58 REMARK 500 SER A 191 151.33 178.05 REMARK 500 GLU A 194 128.68 -26.28 REMARK 500 LYS A 219 169.79 171.17 REMARK 500 LYS A 220 -176.01 71.70 REMARK 500 GLN A 222 44.25 -99.30 REMARK 500 GLU A 224 130.81 -175.00 REMARK 500 MET A 230 62.41 28.27 REMARK 500 ASP A 237 35.08 -155.33 REMARK 500 THR A 240 177.67 179.92 REMARK 500 ILE A 270 -27.01 -147.83 REMARK 500 VAL A 276 15.61 -141.04 REMARK 500 LEU A 283 20.23 -142.00 REMARK 500 ALA A 288 175.56 68.95 REMARK 500 GLU A 291 128.31 178.64 REMARK 500 GLN A 334 29.73 48.59 REMARK 500 PHE A 346 -16.01 81.55 REMARK 500 PRO A 412 -179.69 -64.82 REMARK 500 ASP A 443 148.36 -174.70 REMARK 500 ALA A 445 146.30 -173.58 REMARK 500 ASN A 471 69.55 66.72 REMARK 500 SER B 3 107.38 -166.83 REMARK 500 PRO B 14 111.15 -38.46 REMARK 500 LYS B 20 56.06 -149.90 REMARK 500 GLU B 53 -9.20 -59.34 REMARK 500 ILE B 63 -160.68 -123.68 REMARK 500 LYS B 65 -156.68 -75.34 REMARK 500 LYS B 66 -73.51 -63.07 REMARK 500 ASP B 67 -77.99 -76.75 REMARK 500 ASP B 86 102.16 -52.50 REMARK 500 TRP B 88 75.81 -108.14 REMARK 500 LEU B 92 172.69 70.96 REMARK 500 ILE B 94 111.89 -37.25 REMARK 500 PRO B 97 98.59 -67.76 REMARK 500 VAL B 148 -163.37 -108.27 REMARK 500 PRO B 170 2.41 -67.03 REMARK 500 MET B 184 -124.78 55.12 REMARK 500 LEU B 193 -162.42 -74.85 REMARK 500 TRP B 212 47.99 -101.53 REMARK 500 REMARK 500 THIS ENTRY HAS 61 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UDR A 556 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3IS9 RELATED DB: PDB DBREF 3IRX A 1 555 UNP P03366 POL_HV1B1 600 1154 DBREF 3IRX B 1 428 UNP P03366 POL_HV1B1 600 1027 SEQADV 3IRX GLY A -2 UNP P03366 EXPRESSION TAG SEQADV 3IRX MET A -1 UNP P03366 EXPRESSION TAG SEQADV 3IRX VAL A 0 UNP P03366 EXPRESSION TAG SEQADV 3IRX ALA A 172 UNP P03366 LYS 771 ENGINEERED MUTATION SEQADV 3IRX ALA A 173 UNP P03366 LYS 772 ENGINEERED MUTATION SEQADV 3IRX SER A 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQADV 3IRX SER B 280 UNP P03366 CYS 879 ENGINEERED MUTATION SEQRES 1 A 558 GLY MET VAL PRO ILE SER PRO ILE GLU THR VAL PRO VAL SEQRES 2 A 558 LYS LEU LYS PRO GLY MET ASP GLY PRO LYS VAL LYS GLN SEQRES 3 A 558 TRP PRO LEU THR GLU GLU LYS ILE LYS ALA LEU VAL GLU SEQRES 4 A 558 ILE CYS THR GLU MET GLU LYS GLU GLY LYS ILE SER LYS SEQRES 5 A 558 ILE GLY PRO GLU ASN PRO TYR ASN THR PRO VAL PHE ALA SEQRES 6 A 558 ILE LYS LYS LYS ASP SER THR LYS TRP ARG LYS LEU VAL SEQRES 7 A 558 ASP PHE ARG GLU LEU ASN LYS ARG THR GLN ASP PHE TRP SEQRES 8 A 558 GLU VAL GLN LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS SEQRES 9 A 558 LYS LYS LYS SER VAL THR VAL LEU ASP VAL GLY ASP ALA SEQRES 10 A 558 TYR PHE SER VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR SEQRES 11 A 558 THR ALA PHE THR ILE PRO SER ILE ASN ASN GLU THR PRO SEQRES 12 A 558 GLY ILE ARG TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP SEQRES 13 A 558 LYS GLY SER PRO ALA ILE PHE GLN SER SER MET THR LYS SEQRES 14 A 558 ILE LEU GLU PRO PHE ALA ALA GLN ASN PRO ASP ILE VAL SEQRES 15 A 558 ILE TYR GLN TYR MET ASP ASP LEU TYR VAL GLY SER ASP SEQRES 16 A 558 LEU GLU ILE GLY GLN HIS ARG THR LYS ILE GLU GLU LEU SEQRES 17 A 558 ARG GLN HIS LEU LEU ARG TRP GLY LEU THR THR PRO ASP SEQRES 18 A 558 LYS LYS HIS GLN LYS GLU PRO PRO PHE LEU TRP MET GLY SEQRES 19 A 558 TYR GLU LEU HIS PRO ASP LYS TRP THR VAL GLN PRO ILE SEQRES 20 A 558 VAL LEU PRO GLU LYS ASP SER TRP THR VAL ASN ASP ILE SEQRES 21 A 558 GLN LYS LEU VAL GLY LYS LEU ASN TRP ALA SER GLN ILE SEQRES 22 A 558 TYR PRO GLY ILE LYS VAL ARG GLN LEU SER LYS LEU LEU SEQRES 23 A 558 ARG GLY THR LYS ALA LEU THR GLU VAL ILE PRO LEU THR SEQRES 24 A 558 GLU GLU ALA GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE SEQRES 25 A 558 LEU LYS GLU PRO VAL HIS GLY VAL TYR TYR ASP PRO SER SEQRES 26 A 558 LYS ASP LEU ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY SEQRES 27 A 558 GLN TRP THR TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN SEQRES 28 A 558 LEU LYS THR GLY LYS TYR ALA ARG MET ARG GLY ALA HIS SEQRES 29 A 558 THR ASN ASP VAL LYS GLN LEU THR GLU ALA VAL GLN LYS SEQRES 30 A 558 ILE THR THR GLU SER ILE VAL ILE TRP GLY LYS THR PRO SEQRES 31 A 558 LYS PHE LYS LEU PRO ILE GLN LYS GLU THR TRP GLU THR SEQRES 32 A 558 TRP TRP THR GLU TYR TRP GLN ALA THR TRP ILE PRO GLU SEQRES 33 A 558 TRP GLU PHE VAL ASN THR PRO PRO LEU VAL LYS LEU TRP SEQRES 34 A 558 TYR GLN LEU GLU LYS GLU PRO ILE VAL GLY ALA GLU THR SEQRES 35 A 558 PHE TYR VAL ASP GLY ALA ALA ASN ARG GLU THR LYS LEU SEQRES 36 A 558 GLY LYS ALA GLY TYR VAL THR ASN LYS GLY ARG GLN LYS SEQRES 37 A 558 VAL VAL PRO LEU THR ASN THR THR ASN GLN LYS THR GLU SEQRES 38 A 558 LEU GLN ALA ILE TYR LEU ALA LEU GLN ASP SER GLY LEU SEQRES 39 A 558 GLU VAL ASN ILE VAL THR ASP SER GLN TYR ALA LEU GLY SEQRES 40 A 558 ILE ILE GLN ALA GLN PRO ASP LYS SER GLU SER GLU LEU SEQRES 41 A 558 VAL ASN GLN ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS SEQRES 42 A 558 VAL TYR LEU ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY SEQRES 43 A 558 GLY ASN GLU GLN VAL ASP LYS LEU VAL SER ALA GLY SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET UDR A 556 36 HETNAM UDR (E)-S-METHYL 5-(1-(3,7-DIMETHYL-2-OXO-2,3- HETNAM 2 UDR DIHYDROBENZO[D]OXAZOL-5-YL)-5-(5-METHYL-1,3,4- HETNAM 3 UDR OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3-METHY HETNAM 4 UDR LBENZOTHIOATE HETSYN UDR S-METHYL 5-[(1E)-1-(3,7-DIMETHYL-2-OXO-2,3-DIHYDRO-1,3- HETSYN 2 UDR BENZOXAZOL-5-YL)-5-(5-METHYL-1,3,4-OXADIAZOL-2-YL) HETSYN 3 UDR PENT-1-EN-1-YL]-2-METHOX Y-3-METHYLBENZENECARBOTHIOATE FORMUL 3 UDR C27 H29 N3 O5 S HELIX 1 1 THR A 27 GLY A 45 1 19 HELIX 2 2 PHE A 77 LYS A 82 1 6 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 GLY A 112 TYR A 115 5 4 HELIX 5 5 ASP A 121 THR A 128 5 8 HELIX 6 6 SER A 134 GLU A 138 5 5 HELIX 7 7 GLY A 155 GLN A 174 1 20 HELIX 8 8 GLU A 194 LEU A 209 1 16 HELIX 9 9 LEU A 210 GLY A 213 5 4 HELIX 10 10 THR A 253 SER A 268 1 16 HELIX 11 11 VAL A 276 LYS A 281 1 6 HELIX 12 12 GLU A 297 GLU A 302 1 6 HELIX 13 13 GLU A 305 LEU A 310 1 6 HELIX 14 14 ASN A 363 GLY A 384 1 22 HELIX 15 15 GLN A 394 TYR A 405 1 12 HELIX 16 16 THR A 473 SER A 489 1 17 HELIX 17 17 SER A 499 ALA A 508 1 10 HELIX 18 18 SER A 515 LYS A 528 1 14 HELIX 19 19 GLY A 544 SER A 553 1 10 HELIX 20 20 THR B 27 GLU B 44 1 18 HELIX 21 21 PHE B 77 THR B 84 1 8 HELIX 22 22 GLY B 112 VAL B 118 5 7 HELIX 23 23 PHE B 124 ALA B 129 5 6 HELIX 24 24 SER B 134 GLU B 138 5 5 HELIX 25 25 GLY B 155 LEU B 168 1 14 HELIX 26 26 LEU B 168 LYS B 173 1 6 HELIX 27 27 GLU B 194 ARG B 211 1 18 HELIX 28 28 THR B 253 TYR B 271 1 19 HELIX 29 29 VAL B 276 LYS B 281 1 6 HELIX 30 30 THR B 296 GLU B 312 1 17 HELIX 31 31 ASN B 363 GLY B 384 1 22 HELIX 32 32 GLN B 394 TRP B 402 1 9 HELIX 33 33 THR B 403 TYR B 405 5 3 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N PHE A 130 O TYR A 144 SHEET 1 B 2 VAL A 60 ILE A 63 0 SHEET 2 B 2 ARG A 72 VAL A 75 -1 O LEU A 74 N PHE A 61 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 C 3 VAL A 179 TYR A 183 -1 N TYR A 181 O TYR A 188 SHEET 1 D 2 LEU A 228 TRP A 229 0 SHEET 2 D 2 TYR A 232 GLU A 233 -1 O TYR A 232 N TRP A 229 SHEET 1 E 5 LYS A 347 ALA A 355 0 SHEET 2 E 5 GLN A 336 GLU A 344 -1 N ILE A 341 O LEU A 349 SHEET 3 E 5 ILE A 326 GLY A 333 -1 N ILE A 326 O TYR A 342 SHEET 4 E 5 LYS A 388 LEU A 391 1 O LYS A 390 N ALA A 327 SHEET 5 E 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 F 2 HIS A 361 THR A 362 0 SHEET 2 F 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 G 5 GLN A 464 THR A 470 0 SHEET 2 G 5 LEU A 452 THR A 459 -1 N GLY A 453 O LEU A 469 SHEET 3 G 5 GLU A 438 ALA A 446 -1 N TYR A 441 O VAL A 458 SHEET 4 G 5 GLU A 492 THR A 497 1 O ASN A 494 N PHE A 440 SHEET 5 G 5 LYS A 530 TRP A 535 1 O ALA A 534 N ILE A 495 SHEET 1 H 3 ILE B 47 LYS B 49 0 SHEET 2 H 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 H 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 I 2 VAL B 60 ILE B 63 0 SHEET 2 I 2 ARG B 72 VAL B 75 -1 O LEU B 74 N PHE B 61 SHEET 1 J 4 VAL B 179 TYR B 183 0 SHEET 2 J 4 ASP B 186 SER B 191 -1 O TYR B 188 N TYR B 181 SHEET 3 J 4 SER B 105 ASP B 110 -1 N THR B 107 O VAL B 189 SHEET 4 J 4 GLY B 231 LEU B 234 -1 O LEU B 234 N VAL B 106 SHEET 1 K 5 LYS B 347 GLY B 352 0 SHEET 2 K 5 GLN B 336 GLU B 344 -1 N ILE B 341 O LYS B 350 SHEET 3 K 5 ILE B 326 GLY B 333 -1 N ILE B 326 O TYR B 342 SHEET 4 K 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 K 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 SITE 1 AC1 12 PRO A 95 LEU A 100 VAL A 106 VAL A 108 SITE 2 AC1 12 TYR A 181 TYR A 188 GLY A 190 PHE A 227 SITE 3 AC1 12 LEU A 228 TRP A 229 LEU A 234 HIS A 235 CRYST1 164.639 75.385 110.662 90.00 100.08 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006074 0.000000 0.001080 0.00000 SCALE2 0.000000 0.013265 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009178 0.00000